ALLO - Allogene Therapeutics Inc. (ALLO) CEO David Chang on Q4 2021 Results - Earnings Call Transcript

Allogene Therapeutics, Inc. (ALLO) Q4 2021 Earnings Conference Call February 23, 2022 05:00 PM ET Company Participants Christine Cassiano - Chief Communications Officer David Chang - President & Chief Executive Officer Rafael Amado - Executive Vice President, Research & Development & Chief Medical Officer Alison Moore - Chief Technical Officer Eric Schmidt - Chief Financial Officer Conference Call Participants Michael Yee - Jefferies Salveen Richter - Goldman Sachs Tyler Van Buren - Cowen Mark Breidenbach - Oppenheimer Reni Benjamin - JMP Securities Luca Issi - RBC Asthika Goonewardene - Truist Securities John Newman - Canaccord Raju Prasad - William Blair Dane Leone – Raymond James Presentation Operator Hello and thank you for standing by, and welcome to Allogene Therapeutics Fourth Quarter and Year End 2021 Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please

For further details see:

Allogene Therapeutics, Inc. (ALLO) CEO David Chang on Q4 2021 Results - Earnings Call Transcript